BioNxt Solutions Inc.
BNXTF
$0.26
$0.015.90%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -8.10K | 8.20K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -8.10K | 8.20K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -8.10K | 8.20K | -- |
| SG&A Expenses | 431.70K | 1.94M | 1.10M | 823.80K | 550.80K |
| Depreciation & Amortization | 500.00 | 800.00 | 3.20K | 4.00K | 4.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 633.60K | 2.00M | 1.24M | 927.80K | 784.00K |
| Operating Income | -633.60K | -2.00M | -1.25M | -919.70K | -784.00K |
| Income Before Tax | -806.30K | -3.05M | -1.68M | -1.16M | -939.80K |
| Income Tax Expenses | -- | -- | -141.60K | -- | -- |
| Earnings from Continuing Operations | -806.30K | -3.05M | -1.54M | -1.16M | -939.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -806.30K | -3.05M | -1.54M | -1.16M | -939.80K |
| EBIT | -633.60K | -2.00M | -1.25M | -919.70K | -784.00K |
| EBITDA | -633.10K | -2.00M | -1.25M | -915.60K | -779.10K |
| EPS Basic | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 129.96M | 125.25M | 121.87M | 117.65M | 116.08M |
| Average Diluted Shares Outstanding | 129.96M | 125.25M | 121.87M | 117.65M | 116.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |